Back to Search
Start Over
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum.
- Source :
-
Revue neurologique [Rev Neurol (Paris)] 2020 Jun; Vol. 176 (6), pp. 523-525. Date of Electronic Publication: 2020 Apr 27. - Publication Year :
- 2020
- Subjects :
- Antibodies, Monoclonal, Humanized therapeutic use
COVID-19
Female
Fingolimod Hydrochloride therapeutic use
Humans
Middle Aged
Multiple Sclerosis, Chronic Progressive diagnostic imaging
Natalizumab therapeutic use
Pandemics
SARS-CoV-2
Betacoronavirus
Coronavirus Infections diagnosis
Immunosuppressive Agents therapeutic use
Multiple Sclerosis, Chronic Progressive drug therapy
Multiple Sclerosis, Relapsing-Remitting drug therapy
Pneumonia, Viral diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 0035-3787
- Volume :
- 176
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Revue neurologique
- Publication Type :
- Report
- Accession number :
- 32362357
- Full Text :
- https://doi.org/10.1016/j.neurol.2020.04.009